超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

復旦張江
上海復旦張江生物醫藥股份有限公司，一九九六年十一月創建于上海浦東張江高科技園區之“張江藥谷”，上海醫藥集團股份有限公司、中國通用技術（集團）控股有限責任公司、張江高科技園區開發股份有限公司和復旦資產經營有限公司等知名企業和大學為公司主要股東。

本著"我們多一分探索，人類多一分健康"的信念，公司主要從事生物醫藥的創新研究、開發、生產和銷售，力求成為一家以知識產權為核心源泉的生物醫藥創新企業。經過多年的不懈努力，公司在基因工程藥物、光動力藥物、醫學診斷及藥物傳輸系統等領域不斷推出新產品，形成了明顯的競爭優勢，預計未來每年將有一二個新藥投放市場。

憑籍在生物醫藥領域的實力，公司多次擔綱國家級研發項目，包括國家重點科技項目計劃和國家高技術研究發展計劃（八六三計劃）等。一九九八年以來，公司被連續認定為“高新技術企業”，一九九九年，公司被國家人事部批準為“企業博士后科研工作站”。二〇〇二年八月，公司在香港創業板成功上市（股票代碼：8231）。

公司現控股上海摩根談國際生命科學中心有限公司、上海靶點藥物有限公司及泰州復旦張江藥業有限公司，參股上海先導藥業有限公司。公司人力資源豐富，技術力量強大，近200名高素質的員工將推動公司不斷創新，實現飛躍。

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (FDZJ) was established in Novmber,1996 and located in the “Drug Valley”, Zhangjiang Hi-tech Park, Pudong District, Shanghai. The shareholders include Shanghai Pharmaceuticals Holding Co.,Ltd., Genertech Holding Co., Ltd., Zhangjiang Hi-tech Development Co., Ltd., Fudan University.

With the philosophy of “the more we probe, the healthier the people will be”, aiming at becoming an innovative bio-medical company possessing intellectual properties as the core competitive force, the company deals with new drug R&D as well as production and sales. Many years of the persistent effort have brought many new results in the R&D of genetic engineering drugs, photodynamic drugs, diagnosis reagents and new dosage forms with the improving drug delivery properties and competitive advantage for the company. One or two new drugs will be launched every year since this year.

Owing to the strength of the R&D in bio-pharmaceutical field, the company has played an important role in many national R&D projects, such as national key project of science and technology development and national hi-tech R&D projects. The company has continuously characterized as an Advance Science and Technology Enterprise since 1998, recognized as a Postdoctoral Study Station since 1999 and fulfilled the procedure of IPO listed in Hong Kong GEM since 2002.

The company organized four subsidiary companies: Shanghai Morgan Tan International Centre for Life Science, Taizhou Fudan-Zhangjiang Pharmaceutical Co.,Ltd., Shanghai TargetDrug Pharmaceutical Co.,Ltd. And Shanghai Lead Discovery Pharmaceutical Co., Ltd. Due to the rich brain-source and strong technical source, about 200 staff member well educated and trained will surely create more and push the company go forward rapidly.